ArcticZymes Technologies ASA (AZT.OL)
NOK 13.58
(-2.3%)
NOK 13.58
(-2.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 30.02 Million NOK | -12.46% |
| 2022 | 34.3 Million NOK | -12.65% |
| 2021 | 39.26 Million NOK | 53.5% |
| 2020 | 25.58 Million NOK | -17.83% |
| 2019 | 31.13 Million NOK | 120.54% |
| 2018 | 14.11 Million NOK | -16.32% |
| 2017 | 16.87 Million NOK | -4.94% |
| 2016 | 17.74 Million NOK | 23.91% |
| 2015 | 14.32 Million NOK | 16.79% |
| 2014 | 12.26 Million NOK | 8.95% |
| 2013 | 11.25 Million NOK | 8.99% |
| 2012 | 10.32 Million NOK | -2.67% |
| 2011 | 10.61 Million NOK | -67.44% |
| 2010 | 32.59 Million NOK | 4.97% |
| 2009 | 31.04 Million NOK | 8.96% |
| 2008 | 28.49 Million NOK | 83.86% |
| 2007 | 15.49 Million NOK | -14.07% |
| 2006 | 18.03 Million NOK | 40.51% |
| 2005 | 12.83 Million NOK | 36.61% |
| 2004 | 9.39 Million NOK | 7.58% |
| 2003 | 8.73 Million NOK | 114.65% |
| 2002 | -59.59 Million NOK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 21.51 Million NOK | -26.18% |
| 2024 Q1 | 29.13 Million NOK | -2.95% |
| 2023 Q4 | 30.02 Million NOK | 2.59% |
| 2023 Q2 | 28.46 Million NOK | -1.45% |
| 2023 FY | 30.02 Million NOK | -12.46% |
| 2023 Q1 | 28.88 Million NOK | -15.79% |
| 2023 Q3 | 29.26 Million NOK | 2.81% |
| 2022 Q1 | 27.61 Million NOK | -29.68% |
| 2022 Q3 | 33.51 Million NOK | 6.7% |
| 2022 Q4 | 34.3 Million NOK | 2.33% |
| 2022 FY | 34.3 Million NOK | -12.65% |
| 2022 Q2 | 31.41 Million NOK | 13.77% |
| 2021 FY | 39.26 Million NOK | 53.5% |
| 2021 Q1 | 21.57 Million NOK | -15.66% |
| 2021 Q2 | 31.08 Million NOK | 44.08% |
| 2021 Q3 | 36.53 Million NOK | 17.52% |
| 2021 Q4 | 39.26 Million NOK | 7.48% |
| 2020 Q1 | 31.47 Million NOK | 1.09% |
| 2020 Q3 | 24.83 Million NOK | -5.77% |
| 2020 Q2 | 26.35 Million NOK | -16.25% |
| 2020 Q4 | 25.58 Million NOK | 3.0% |
| 2020 FY | 25.58 Million NOK | -17.83% |
| 2019 Q2 | 26.34 Million NOK | -7.17% |
| 2019 Q3 | 30.58 Million NOK | 16.09% |
| 2019 FY | 31.13 Million NOK | 120.54% |
| 2019 Q4 | 31.13 Million NOK | 1.8% |
| 2019 Q1 | 28.37 Million NOK | 101.03% |
| 2018 Q1 | 12.51 Million NOK | -25.79% |
| 2018 Q2 | 10.58 Million NOK | -15.42% |
| 2018 Q3 | 12.82 Million NOK | 21.13% |
| 2018 FY | 14.11 Million NOK | -16.32% |
| 2018 Q4 | 14.11 Million NOK | 10.06% |
| 2017 FY | 16.87 Million NOK | -4.94% |
| 2017 Q4 | 16.87 Million NOK | 10.61% |
| 2017 Q3 | 15.25 Million NOK | 10.1% |
| 2017 Q2 | 13.85 Million NOK | 5.28% |
| 2017 Q1 | 13.15 Million NOK | -25.85% |
| 2016 Q4 | 17.74 Million NOK | 37.13% |
| 2016 FY | 17.74 Million NOK | 23.91% |
| 2016 Q2 | 9.48 Million NOK | -4.7% |
| 2016 Q1 | 9.95 Million NOK | -30.48% |
| 2016 Q3 | 12.94 Million NOK | 36.38% |
| 2015 Q2 | 7.74 Million NOK | -5.2% |
| 2015 Q3 | 10.92 Million NOK | 41.09% |
| 2015 Q1 | 8.16 Million NOK | -33.4% |
| 2015 Q4 | 14.32 Million NOK | 31.12% |
| 2015 FY | 14.32 Million NOK | 16.79% |
| 2014 Q1 | 9.93 Million NOK | -11.78% |
| 2014 Q3 | 8.61 Million NOK | 10.92% |
| 2014 Q4 | 12.26 Million NOK | 42.41% |
| 2014 Q2 | 7.76 Million NOK | -21.82% |
| 2014 FY | 12.26 Million NOK | 8.95% |
| 2013 Q1 | 10.26 Million NOK | -0.63% |
| 2013 FY | 11.25 Million NOK | 8.99% |
| 2013 Q4 | 11.25 Million NOK | 32.55% |
| 2013 Q3 | 8.49 Million NOK | -3.55% |
| 2013 Q2 | 8.8 Million NOK | -14.21% |
| 2012 Q1 | 10.01 Million NOK | -5.61% |
| 2012 FY | 10.32 Million NOK | -2.67% |
| 2012 Q2 | 7.81 Million NOK | -21.93% |
| 2012 Q3 | 8.43 Million NOK | 7.85% |
| 2012 Q4 | 10.32 Million NOK | 22.47% |
| 2011 Q1 | 10.93 Million NOK | -66.44% |
| 2011 Q2 | 7.04 Million NOK | -35.58% |
| 2011 Q3 | 9.89 Million NOK | 40.49% |
| 2011 Q4 | 10.61 Million NOK | 7.19% |
| 2011 FY | 10.61 Million NOK | -67.44% |
| 2010 Q4 | 32.59 Million NOK | 0.0% |
| 2010 FY | 32.59 Million NOK | 4.97% |
| 2009 FY | 31.04 Million NOK | 8.96% |
| 2008 FY | 28.49 Million NOK | 83.86% |
| 2007 FY | 15.49 Million NOK | -14.07% |
| 2006 FY | 18.03 Million NOK | 40.51% |
| 2005 FY | 12.83 Million NOK | 36.61% |
| 2004 FY | 9.39 Million NOK | 7.58% |
| 2003 FY | 8.73 Million NOK | 114.65% |
| 2002 FY | -59.59 Million NOK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Arctic Bioscience AS | 41.69 Million NOK | 27.985% |
| Aqua Bio Technology ASA | 15.72 Million NOK | -90.968% |
| BerGenBio ASA | 46.85 Million NOK | 35.923% |
| Hofseth BioCare ASA | 348.97 Million NOK | 91.396% |
| PCI Biotech Holding ASA | 5 Million NOK | -499.561% |
| Thor Medical ASA | 58.91 Million NOK | 49.031% |
| Ultimovacs ASA | 69.64 Million NOK | 56.889% |